DocDollars

Verrica Pharmaceuticals Inc.

PA · United States · Reporting entity ID 100000851821

Total reported 2019–2025
$1.69M
#1,100 of 2,960 reporting companies — 0% of all reported industry payments
$1.59M in general payments across 19,170 records, plus $104K in research funding across 13 records.

How it breaks down

General payments $1,585,398
Research funding $103,695

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Verrica Pharmaceuticals Inc. reported $1.69M to US doctors and teaching hospitals from 2019 to 2025, ranking #1,100 of 2,960 reporting companies. 6% of that was research funding and 94% general payments such as consulting, speaking, food and travel. 19,170 general payment records and 13 research records were filed.

Common questions about Verrica Pharmaceuticals Inc.

How much has Verrica Pharmaceuticals Inc. paid US doctors?

Verrica Pharmaceuticals Inc. reported $1,689,093 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $1,585,398 in general payments, $103,695 in research funding.

How does Verrica Pharmaceuticals Inc. rank among drug and device companies?

It ranks #1,100 of 2,960 reporting entities by total reported value, about 0% of all industry payments in the dataset.

Does a payment from Verrica Pharmaceuticals Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.